Capstan Medical, a developer of minimally invasive technology to address heart valve disease, today announced an oversubscribed $31.4 million Series B investment led by Eclipse. Additional participating investors include Intuitive Ventures and Puma Venture Capital, a new firm founded by Amit Hazan, a veteran Wall Street medical technology analyst, and Dr. Vipul Patel, a renowned robotic surgeon who has performed more robotic procedures than any other surgeon worldwide.
Since 2020, Capstan Medical has carefully curated a team of heart valve implant experts and seasoned robotics engineers to address the rising need for minimally invasive options for treating heart valve disease. CEO Maggie Nixon brings more than 20 years of experience at Intuitive Surgical to the company, and co-founder and CTO Dan Wallace has dedicated his career to creating products that reduce the pain and complications of surgery, having developed solutions at Intuitive Surgical, Hansen Medical, Auris Health, Cephea Valve Technologies and more.
“Open heart surgery is traumatic and an unrealistic treatment option for many – there is significant need for better options for patients to address their heart valve disease. Capstan Medical is creating a new standard of heart valve intervention by bringing a minimally invasive treatment option to patients who need it most,” said Nixon. “There is rarely such strong alignment between a group of investors and a leadership team on the value robotics can bring to minimizing patient impact, while enabling exceptional outcomes.”
GT is proud to have partnered with the team since Series A2.